Ending Cancer as We Know It: The Game Changing Potential of GCT
Tuesday, May 3, 2022
50 years after the nation’s War on Cancer was launched, do new treatment innovations have us at a turning point to end cancer “as we know it”.
- Moderator:
-
- Erin Harris
-
- Chief Editor, Cell & Gene
- Panelists:
-
- David Scadden, MD
-
- Director, Center for Regenerative Medicine, MGH
- Gerald and Darlene Jordan Professor of Medicine, HMS
- Norman Sharpless, MD
-
- Former Director, National Cancer Institute